Back to search

Article

A prioritized medium-throughput screen identifies FGF4, FGF5, FGF8F, FGF19 and FGF21 as protective factors for human stem cell derived insulin secreting beta cells

2025-02-16

Abstract excerpt

<h4> Abstract </h4> Stem cell-derived β-like cells (SCβ cells) are a potential alternative to cadaveric β cells for replacement therapy in type 1 diabetes. However, SCβ cells face a multitude of stresses that must be overcome. Both β cells and SCβ cells reside in complex microtissues and can therefore be modulated by hundreds of autocrine/paracrine signals within these islets or spheroids. Here, we leveraged mul...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dc45e2c0-d210-520d-9387-ea01156fcf40
DOI
10.1101/2025.02.12.637990
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A prioritized medium-throughput screen identifies FGF4, FGF5, FGF8F, FGF19 and FGF21 as protective factors for human stem cell derived insulin secreting beta cellsDOI 10.1101/2025.02.12.637990
Select a neighboring publication to make it the new centre.